Chromatin Immunoprecipitation Sequencing or ChIP-seq is a method which
is used to detect the interaction between DNA and Protein using next
generation sequencing. It combines the chromatin immunoprecipitation
with DNA sequencing for the identification of the binding sites of
DNA-associated proteins. It is a type of tool that helps in determining
the location of the DNA binding sites on the genome for a protein of
interest.

Chromatin Immunoprecipitation sequencing helps the researcher for the
screening and identification of the protein binding sites on the
complete chromosomal scale with high and improved accuracy and
efficiency.

Rising incidence of immunology cases which required to test
antigen-antibody interaction is a vital factor which positively
influencing the growth of the market. Government has taken several
initiatives and increases fund to promote the research conducted on
combining chromatin immunoprecipitation and next generation DNA
sequencing is also driving the market. The Chromatin Immunoprecipitation
Sequencing is also useful for early detection of metabolic and
obesity-related disorders. This is expected to fuelling the chromatin
immunoprecipitation sequencing market during the forecast period.
Although few factors such as cellular composition of the tissue, frozen
sample availability, high lipid content can restrain the concern market.

Chromatin Immunoprecipitation Sequencing Market: Segmentation

To gain a comprehensive and a better understanding of the future market
equity, the market report is segmented based on product type,
application, end user and region.

Global Chromatin Immunoprecipitation Sequencing market has witnessed
growth due to expanding demand for Immunoprecipitation testing for
various diseases like cancer and certain cardiovascular conditions.
Chromatin Immunoprecipitation Sequencing is preferred over ChIP-on-chip.
The DNA fragments while the Immunoprecipitation are isolated and can be
identified by various methods like, DNA microarray, PCR and DNA
sequencing. Combining NGS with ChIP, is also expected to contribute to
boost the demand for Chromatin Immunoprecipitation Sequencing.

Chromatin Immunoprecipitation Sequencing Market: Region-wise Outlook

Geography wise, Chromatin Immunoprecipitation Sequencing market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s Chromatin Immunoprecipitation Sequencing market is expanding because of high adoption rate and it will remain dominant over the period of forecast due to growing number of research facilities and increased funding by the government for the research studies. Europe’s Chromatin Immunoprecipitation Sequencing market is also expected to grow at a significant rate due to improved availability of Chromatin Immunoprecipitation Sequencing kits and growing diagnostic centers in the region. Asia-Pacific’s Chromatin Immunoprecipitation Sequencing market is anticipated to grow at a decent rate due to low healthcare expenditure.